IE 11 is not supported. For an optimal experience visit our site on another browser.

WHO declares monkeypox an international public health emergency

The same designation was used in the past for Covid-19, Ebola, Zika, H1N1 flu and polio. More than 16,500 monkeypox cases have been recorded worldwide.

The World Health Organization on Saturday declared monkeypox a public health emergency of international concern, a designation reserved for the most serious global disease outbreaks.

That puts monkeypox on the same list as six other outbreaks with the same WHO label since 2007: Covid-19, Zika, H1N1 flu, polio and Ebola, which has been designated an emergency twice.

The WHO decision came after an emergency committee convened on Thursday to assess the spread of monkeypox and determine the severity of its threat.

WHO Director-General Tedros Adhanom Ghebreyesus made the decision to issue the declaration despite a lack of consensus among experts serving on the U.N. health agency’s emergency committee. It was the first time the chief of the U.N. health agency has taken such an action.

“We have an outbreak that has spread around the world rapidly through new modes of transmission about which we understand too little and which meets the criteria in the international health regulations,” Tedros said.

“I know this has not been an easy or straightforward process and that there are divergent views among the members” of the committee, he added.

The world has seen more than 16,500 monkeypox cases so far this year in 68 countries where the disease is not endemic, according to the Centers for Disease Control and Prevention. The U.S. alone has recorded more than 2,500 cases since May, though that’s almost certainly an undercount. 

For a disease outbreak to qualify as an international public health emergency, it must be an "extraordinary event" that poses a health risk to more than one country and may require an immediate, coordinated international response, according to the WHO.

The same emergency committee decided last month that monkeypox didn't yet meet those standards, though Tedros said a few committee members "expressed differing views." At the time, more than 4,000 monkeypox cases had been reported globally across 47 countries and territories.

Vaccines could help curb transmission

Monkeypox spreads through close physical contact, including kissing or sexual contact, as well as through respiratory droplets and contaminated items like clothing or bedding.

Anyone who has been in close contact with a monkeypox patient can get infected, but since the start of the outbreak, cases have been largely concentrated among men who have sex with men.

“Although I am declaring a public health emergency of international concern for the moment, this is an outbreak that is concentrated among men who have sex with men, especially those with multiple sexual partners,” Tedros said. “That means that this is an outbreak that can be stopped with the right strategies in the right groups.”

Most people with monkeypox develop a rash, according to WHO. For some, the rash may be hard to spot — just one or two lesions — while others can develop widespread lesions. In this outbreak so far, the rashes have often been found around the genital and anal region, on the face, or on the palms of hands and soles of feet. Some people may also get lesions inside the mouth, throat, vagina and anus.

Symptoms like fever, swollen lymph nodes, headaches, muscle aches, back pain and fatigue sometimes follow a rash.

In Europe and the U.S., health authorities are relying on increased vaccination and testing to reduce transmission and prevent monkeypox from becoming endemic.

Image: A medical laboratory technician places suspected monkeypox samples inside an automated nucleic acid extractor before being PCR tested at the microbiology laboratory of La Paz Hospital on June 6, 2022 in Madrid.
A medical laboratory technician places suspected monkeypox samples inside an automated nucleic acid extractor before being PCR tested at the microbiology laboratory of La Paz Hospital on June 6, 2022 in Madrid.Pablo Blazquez Dominguez / Getty Images file

As of last week, the U.S. had distributed 156,000 doses of the Jynneos vaccine to states and ramped up testing capacity to 70,000 tests per week. Many cities and states are offering vaccine doses to people with known or presumed exposure to the virus, including men who have sex with men and transgender, gender nonconforming or nonbinary residents with multiple sexual partners. 

The European Commission’s Health Emergency Preparedness and Response department said Monday that it had delivered 25,000 vaccine doses to six member states. The U.K.’s National Health Service is also offering doses to close contacts of monkeypox patients with a high risk of exposure, on a case by case basis.

Research suggests that the Jynneos vaccine might prevent monkeypox if given within four days of exposure, meaning it could keep cases from climbing if more people get access to shots.

"Although we are seeing a declining trend in some countries, others are still seeing an increase, and six countries reported their first cases last week," Tedros said at a Wednesday press briefing. "Some of these countries have much less access to diagnostics and vaccines, making the outbreak harder to track, and harder to stop."